From: Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice
Treatment Group
% mice (< 20 mm)
Vehicle
37.5
G-CSF
IL-12 pre
IL-12 post
62.5
IL-12 pre/post
75.0